Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Deciphering cellular states of innate tumor drug responses.

Graudens E, Boulanger V, Mollard C, Mariage-Samson R, Barlet X, Grémy G, Couillault C, Lajémi M, Piatier-Tonneau D, Zaborski P, Eveno E, Auffray C, Imbeaud S.

Genome Biol. 2006;7(3):R19. Epub 2006 Mar 15.

PMID:
16542501
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.

De Angelis PM, Kravik KL, Tunheim SH, Haug T, Reichelt WH.

Mol Cancer. 2004 Apr 26;3:11.

PMID:
15109396
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Clinical determinants of response to irinotecan-based therapy derived from cell line models.

Allen WL, Coyle VM, Jithesh PV, Proutski I, Stevenson L, Fenning C, Longley DB, Wilson RH, Gordon M, Lenz HJ, Johnston PG.

Clin Cancer Res. 2008 Oct 15;14(20):6647-55. doi: 10.1158/1078-0432.CCR-08-0452.

PMID:
18927307
[PubMed - indexed for MEDLINE]
Free Article
4.

Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification.

DePrimo SE, Wong LM, Khatry DB, Nicholas SL, Manning WC, Smolich BD, O'Farrell AM, Cherrington JM.

BMC Cancer. 2003 Feb 7;3:3. Epub 2003 Feb 7.

PMID:
12657164
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.

Boyer J, Allen WL, McLean EG, Wilson PM, McCulla A, Moore S, Longley DB, Caldas C, Johnston PG.

Cancer Res. 2006 Mar 1;66(5):2765-77.

PMID:
16510598
[PubMed - indexed for MEDLINE]
Free Article
6.

Molecular signature for lymphatic metastasis in colorectal carcinomas.

Croner RS, Förtsch T, Brückl WM, Rödel F, Rödel C, Papadopoulos T, Brabletz T, Kirchner T, Sachs M, Behrens J, Klein-Hitpass L, Stürzl M, Hohenberger W, Lausen B.

Ann Surg. 2008 May;247(5):803-10. doi: 10.1097/SLA.0b013e31816bcd49.

PMID:
18438117
[PubMed - indexed for MEDLINE]
7.

Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy.

Godai TI, Suda T, Sugano N, Tsuchida K, Shiozawa M, Sekiguchi H, Sekiyama A, Yoshihara M, Matsukuma S, Sakuma Y, Tsuchiya E, Kameda Y, Akaike M, Miyagi Y.

BMC Cancer. 2009 Dec 2;9:420. doi: 10.1186/1471-2407-9-420.

PMID:
19954513
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Reliability of tumor primary cultures as a model for drug response prediction: expression profiles comparison of tissues versus primary cultures from colorectal cancer patients.

Bellot GL, Tan WH, Tay LL, Koh D, Wang X.

J Cancer Res Clin Oncol. 2012 Mar;138(3):463-82. doi: 10.1007/s00432-011-1115-9. Epub 2011 Dec 21.

PMID:
22186935
[PubMed - indexed for MEDLINE]
9.

Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas.

Violette S, Festor E, Pandrea-Vasile I, Mitchell V, Adida C, Dussaulx E, Lacorte JM, Chambaz J, Lacasa M, Lesuffleur T.

Int J Cancer. 2003 Jan 10;103(2):185-93.

PMID:
12455032
[PubMed - indexed for MEDLINE]
10.

Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations.

Györffy B, Surowiak P, Kiesslich O, Denkert C, Schäfer R, Dietel M, Lage H.

Int J Cancer. 2006 Apr 1;118(7):1699-712.

PMID:
16217747
[PubMed - indexed for MEDLINE]
11.

Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays.

Kang HC, Kim IJ, Park JH, Shin Y, Ku JL, Jung MS, Yoo BC, Kim HK, Park JG.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):272-84.

PMID:
14734480
[PubMed - indexed for MEDLINE]
Free Article
12.

Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer.

Nobili S, Napoli C, Landini I, Morganti M, Cianchi F, Valanzano R, Tonelli F, Cortesini C, Mazzei T, Mini E.

Int J Cancer. 2011 Apr 15;128(8):1935-45. doi: 10.1002/ijc.25514.

PMID:
20560137
[PubMed - indexed for MEDLINE]
13.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]
14.

Clinical applications of the histoculture drug response assay.

Furukawa T, Kubota T, Hoffman RM.

Clin Cancer Res. 1995 Mar;1(3):305-11.

PMID:
9815986
[PubMed - indexed for MEDLINE]
Free Article
15.

Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules.

Tempestini A, Caciagli B, Morganti M, Witort E, Nobili S, Papucci L, Schiavone N, Donnini M, Landini I, Lapucci A, Perna F, Lulli M, Mazzei T, Sobrero A, Mini E, Capaccioli S.

Oncol Res. 2005;16(3):143-56.

PMID:
16925115
[PubMed - indexed for MEDLINE]
16.

Gene expression of vascular endothelial growth factor A, thymidylate synthase, and tissue inhibitor of metalloproteinase 3 in prediction of response to bevacizumab treatment in colorectal cancer patients.

Watanabe T, Kobunai T, Yamamoto Y, Matsuda K, Ishihara S, Nozawa K, Iinuma H, Ikeuchi H.

Dis Colon Rectum. 2011 Aug;54(8):1026-35. doi: 10.1097/DCR.0b013e31821c44af.

PMID:
21730794
[PubMed - indexed for MEDLINE]
17.

Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.

Györffy B, Serra V, Jürchott K, Abdul-Ghani R, Garber M, Stein U, Petersen I, Lage H, Dietel M, Schäfer R.

Oncogene. 2005 Nov 17;24(51):7542-51.

PMID:
16044152
[PubMed - indexed for MEDLINE]
18.

Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer.

Julien S, Merino-Trigo A, Lacroix L, Pocard M, Goéré D, Mariani P, Landron S, Bigot L, Nemati F, Dartigues P, Weiswald LB, Lantuas D, Morgand L, Pham E, Gonin P, Dangles-Marie V, Job B, Dessen P, Bruno A, Pierré A, De Thé H, Soliman H, Nunes M, Lardier G, Calvet L, Demers B, Prévost G, Vrignaud P, Roman-Roman S, Duchamp O, Berthet C.

Clin Cancer Res. 2012 Oct 1;18(19):5314-28. doi: 10.1158/1078-0432.CCR-12-0372. Epub 2012 Jul 23.

PMID:
22825584
[PubMed - indexed for MEDLINE]
Free Article
19.

Specific alterations of microRNA transcriptome and global network structure in colorectal carcinoma after cetuximab treatment.

Ragusa M, Majorana A, Statello L, Maugeri M, Salito L, Barbagallo D, Guglielmino MR, Duro LR, Angelica R, Caltabiano R, Biondi A, Di Vita M, Privitera G, Scalia M, Cappellani A, Vasquez E, Lanzafame S, Basile F, Di Pietro C, Purrello M.

Mol Cancer Ther. 2010 Dec;9(12):3396-409. doi: 10.1158/1535-7163.MCT-10-0137. Epub 2010 Sep 29.

PMID:
20881268
[PubMed - indexed for MEDLINE]
Free Article
20.

Putative chemosensitivity predictive genes in colorectal cancer cell lines for anticancer agents.

Jung JJ, Jeung HC, Lee JO, Kim TS, Chung HC, Rha SY.

Oncol Rep. 2007 Sep;18(3):593-9.

PMID:
17671706
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk